Systemic lupus erythematosus (SLE) is a complex and potentially life-threatening autoimmune disease. Part of the complexity stems from how it can differ from person to person—giving rise to marked ...

Fate Therapeutics, Inc. (NASDAQ:FATE) is among the best get rich quick stocks to buy now. Analysts at H.C. Wainwright have reaffirmed their Neutral rating on Fate Therapeutics, Inc. (NASDAQ:FATE), ...

Please provide your email address to receive an email when new articles are posted on . Antimalarials, azathioprine, colchicine, cyclosporine, sulfasalazine and tacrolimus are deemed compatible with ...

BARCELONA, Spain — Patients with rheumatoid arthritis (RA) who have not responded to first-line methotrexate therapy should be started on a biologic or targeted synthetic disease-modifying ...

BARCELONA, Spain--(BUSINESS WIRE)--Hospital for Special Surgery (HSS) presented a research study at the European Alliance of Associations for Rheumatology (EULAR) Annual Meeting showing that an ...

"Psoriatic arthritis and axial spondyloarthritis are serious, chronic inflammatory diseases that can have a great impact in the daily lives of patients and their families. The data presented at EULAR ...

In 2023, EULAR welcomed Professor Daniel Aletaha to the role, but it is now time for him to hand the baton on to the next in line. We are delighted to have Xenofon Baraliakos as the new EULAR ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced the ...

Enlivex Therapeutics Ltd., a clinical-stage immunotherapy company based in Ness-Ziona, Israel, announced it will present data on Allocetra™, its proprietary macrophage reprogramming cell therapy for ...